Zymeworks Common Stock Target Price and Analyst Consensus
| ZYME Stock | USD 14.09 0.33 2.29% |
The current analyst and expert consensus on Zymeworks Common is Strong Buy, with 5 strong buy opinions. The current projected Zymeworks Common target price consensus is 13.97 with 9 analyst opinions. Check out Macroaxis Advice on Zymeworks Common to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. The most common way Zymeworks Common Stock analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Zymeworks Common executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Zymeworks Common. We strongly encourage you to use your own analysis of Zymeworks Common Stock to validate this buy or sell advice. Zymeworks Common buy-or-sell recommendation module provides average expert sentiment on the projected Zymeworks Common Stock target price to derive its highest and lowest estimates based on projected price volatility of 2.8874.
Lowest Forecast 12.71 | Highest Forecast 15.51 | Target Price 13.97 |
Zymeworks |
It's important to approach Zymeworks Common's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Zymeworks Common price targets
Zymeworks Common's stock target price is an estimate of its future price, usually made by analysts. Using Zymeworks Common's target price to determine if it is a suitable investment can be done through the following steps:- Look at Zymeworks Common's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Zymeworks Common's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Zymeworks Common Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Zymeworks Common is a key component of Zymeworks Common valuation and have some predictive power on the future returns of a Zymeworks Common.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Invested few shares | |
 | Hedge Favorites Invested few shares | |
 | Tech Growth Invested one share | |
 | Steel Works Etc Invested few shares | |
 | Mid Cap ETFs Invested few shares | |
 | Disruptive Technologies Invested over 20 shares | |
 | Corona Opportunity Invested one share | |
 | Impulse Invested few shares | |
 | Artificial Intelligence Invested few shares | |
 | Investor Favorites Invested over 200 shares |
Check out Macroaxis Advice on Zymeworks Common to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Please note, the presentation of Zymeworks Common's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Zymeworks Common's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Zymeworks Common's management manipulating its earnings.